美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA079162"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71610-493-15 71610-493 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20201117 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 200 mg/1 15 TABLET in 1 BOTTLE (71610-493-15)
71610-493-30 71610-493 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20201117 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 200 mg/1 30 TABLET in 1 BOTTLE (71610-493-30)
71610-493-60 71610-493 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20201117 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 200 mg/1 90 TABLET in 1 BOTTLE (71610-493-60)
69097-819-03 69097-819 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 200 mg/1 60 TABLET in 1 BOTTLE (69097-819-03)
69097-819-12 69097-819 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 200 mg/1 500 TABLET in 1 BOTTLE (69097-819-12)
69097-819-15 69097-819 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 200 mg/1 1000 TABLET in 1 BOTTLE (69097-819-15)
43353-697-30 43353-697 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20181112 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 200 mg/1 30 TABLET in 1 BOTTLE (43353-697-30)
76282-281-10 76282-281 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 200 mg/1 1000 TABLET in 1 BOTTLE (76282-281-10)
76282-281-60 76282-281 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 200 mg/1 60 TABLET in 1 BOTTLE (76282-281-60)
71610-486-30 71610-486 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20201211 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 50 mg/1 30 TABLET in 1 BOTTLE (71610-486-30)
71610-486-53 71610-486 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20210407 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 50 mg/1 60 TABLET in 1 BOTTLE (71610-486-53)
71610-486-60 71610-486 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20201110 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 50 mg/1 90 TABLET in 1 BOTTLE (71610-486-60)
71610-486-80 71610-486 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20201116 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 50 mg/1 180 TABLET in 1 BOTTLE (71610-486-80)
69097-817-03 69097-817 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 50 mg/1 60 TABLET in 1 BOTTLE (69097-817-03)
69097-817-12 69097-817 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 50 mg/1 500 TABLET in 1 BOTTLE (69097-817-12)
69097-817-15 69097-817 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 50 mg/1 1000 TABLET in 1 BOTTLE (69097-817-15)
63187-228-30 63187-228 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20190101 N/A ANDA ANDA079162 Proficient Rx LP TOPIRAMATE 50 mg/1 30 TABLET in 1 BOTTLE (63187-228-30)
63187-228-60 63187-228 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20190401 N/A ANDA ANDA079162 Proficient Rx LP TOPIRAMATE 50 mg/1 60 TABLET in 1 BOTTLE (63187-228-60)
63187-228-90 63187-228 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20190101 N/A ANDA ANDA079162 Proficient Rx LP TOPIRAMATE 50 mg/1 90 TABLET in 1 BOTTLE (63187-228-90)
43353-695-60 43353-695 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20110720 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 25 mg/1 90 TABLET in 1 BOTTLE (43353-695-60)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase